Vanhalinna, Finland

Marjaana Heikkila-Hoikka

This inventor holds 4 USPTO granted patents, plus 3 CIPO patents. Top assignee: Leiras Oy. Active years: 1995-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marjaana Heikkila-Hoikka. Retrieved from https://idiyas.com/inventor/marjaana-heikkila-hoikka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 5.7

ph-index = 3

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 1995-2000

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Marjaana Heikkila-Hoikka: Innovator in Therapeutic Agents

Introduction

Marjaana Heikkila-Hoikka is a prominent inventor based in Vanhalinna, Finland. She has made significant contributions to the field of therapeutic agents, particularly in the treatment of bone diseases. With a total of 4 patents to her name, her work has had a notable impact on medical science.

Latest Patents

One of her latest patents is focused on pyridinylbisphosphonates for use as a therapeutic agent. This invention relates to certain optionally ring-substituted pyridinylaminomethylidene bisphosphonic acid tetralkyl esters and their application in treating bone diseases. These diseases include osteolytic bone diseases due to malignancy, Paget's disease, and both primary and secondary osteoporosis.

Career Highlights

Throughout her career, Marjaana has worked with reputable companies such as Leiras Oy and Schering Aktiengesellschaft. Her experience in these organizations has contributed to her expertise in the development of innovative therapeutic solutions.

Collaborations

Marjaana has collaborated with notable colleagues, including Hannu Nikander and Leena Lauren. These partnerships have further enriched her research and development efforts in the field.

Conclusion

Marjaana Heikkila-Hoikka is a distinguished inventor whose work in therapeutic agents continues to influence the treatment of bone diseases. Her innovative patents and collaborations highlight her commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…